home · filing · 0001437749-21-027943
8-K
filed December 6, 2021, 6:59 PM ET
ticker FUL
CIK 0000039368
leadership
confidence high
sentiment neutral
materiality 0.30
H.B. Fuller announces director resignation and election of Dean Sri Zaheer to board
FULLER H B CO
Director Maria Teresa Hilado resigned effective Dec 1, 2021; no disagreement with company.
Dr. Srilata Zaheer elected as Class I director, effective April 6, 2022, serving on Audit and Compensation Committees.
Zaheer receives annual cash retainer of $100,000 (pro-rated), initial grant of 1,300 RSUs, and eligibility for $135,000 phantom stock.
Zaheer is Dean of University of Minnesota's Carlson School and Chair of Federal Reserve Bank of Minneapolis.
Executive movements
Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements .
Appointed
Srilata Zaheer
Director
Effective 2022-04-06
Filed December 6, 2021, 6:59 PM ET
elected Dr. Srilata ("Sri") Zaheer as a Class I director of the Company, effective April 6, 2022
Departed
Maria Teresa Hilado
Director
Effective 2021-12-01
Filed December 6, 2021, 6:59 PM ET
accepted the resignation of Maria Teresa Hilado as a director of the Company effective immediately.
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.95
Srilata Zaheer was elected as Director at FULLER H B CO.
Action elected
Role Director
Exact text from the filing
elected Dr. Srilata ("Sri") Zaheer as a Class I director of the Company, effective April 6, 2022
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Maria Teresa Hilado resigned as Director at FULLER H B CO.
Action resigned
Role Director
Exact text from the filing
accepted the resignation of Maria Teresa Hilado as a director of the Company effective immediately.
View on SEC.gov
Source: SEC EDGAR
accession 0001437749-21-027943
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.